_id
690db429ccc777a4e85d0d31
Ticker
AXON
Name
Axon Enterprise Inc.
Exchange
NASDAQ
Address
17800 North 85th Street, Scottsdale, AZ, United States, 85255
Country
USA
Sector
Industrials
Industry
Aerospace & Defense
Currency
USD
Website
https://www.axon.com
Description
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include axon officer safety plan; taser 10, taser7, taser X26P, taser X2, taser 7 CQ, and civilian series; cameras, such as axon body, axon flex, axon fleet, axon air, axon signal sidearm, axon signal vehicle, axon interview, and axon interview portable kit; software, including axon records, evidence, standards, commander, performance, auto-transcribe, justice, investigate, respond, and justice, my90, and redaction assistant; mobile applications, and training services, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. The company sells its products through its direct sales, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand bility to aggregate live video, data, and sensor feeds. It serves law enforcement, federal, correction, fire, EMS, campus, justice healthcare, retail, private security, and personal safety industries. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
Last Close
564.28
Volume
445332
Current Price
551.79
Change
-2.213440136102646
Last Updated
2025-11-28T12:38:23.132Z
Image
-
Ipo Date
2001-06-07T00:00:00.000Z
Market Cap
42072690688
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7825703703703705
Sentiment Sources
81
Rating
4.2353
Target Price
822.5
Strong Buy
7
Buy
7
Hold
3
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
710641000
Cost Of Revenue
283293000
Gross Profit
427348000
Operating Expenses
429477000
Operating Income
-2129000
Interest Expense
28912000
Pretax Income
15703000
Net Income
-2186000
Eps
-0.027876963884921446
Dividends Per Share
-
Shares Outstanding
78910466
Income Tax Expense
17889000
EBITDA
64221000
Operating Margin
-0.2995886812047152
Total Other Income Expense Net
17832000
Cash
1423871000
Short Term Investments
952786000
Receivables
700742000
Inventories
317513000
Total Current Assets
4216736000
Property Plant Equipment
283208000
Total Assets
6657365000
Payables
114995000
Short Term Debt
279560000
Long Term Debt
1729366000
Total Liabilities
3629615000
Equity
3027750000
Depreciation
19606000
Change In Working Capital
365032000
Cash From Operations
60014000
Capital Expenditures
26635000
Cash From Investing
590259000
Cash From Financing
159163000
Net Change In Cash
808680000
PE
169.2603
PB
14.290864384443891
ROE
-0.072198827512179
ROA
-0.032835814169720305
FCF
33379000
Fcf Percent
0.046970270502264856
Piotroski FScore
2
Health Score
20
Deep Value Investing Score
4
Defensive Investing Score
6
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
3.5
Growth Investing Score
3.5
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
3.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
710641000
Quarters > 0 > income Statement > cost Of Revenue
283293000
Quarters > 0 > income Statement > gross Profit
427348000
Quarters > 0 > income Statement > operating Expenses
429477000
Quarters > 0 > income Statement > operating Income
-2129000
Quarters > 0 > income Statement > interest Expense
28912000
Quarters > 0 > income Statement > pretax Income
15703000
Quarters > 0 > income Statement > net Income
-2186000
Quarters > 0 > income Statement > eps
-0.027876963884921446
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
78416000
Quarters > 0 > income Statement > income Tax Expense
17889000
Quarters > 0 > income Statement > EBITDA
64221000
Quarters > 0 > income Statement > operating Margin
-0.2995886812047152
Quarters > 0 > income Statement > total Other Income Expense Net
17832000
Quarters > 0 > balance Sheet > cash
1423871000
Quarters > 0 > balance Sheet > short Term Investments
952786000
Quarters > 0 > balance Sheet > receivables
700742000
Quarters > 0 > balance Sheet > inventories
317513000
Quarters > 0 > balance Sheet > total Current Assets
4216736000
Quarters > 0 > balance Sheet > property Plant Equipment
283208000
Quarters > 0 > balance Sheet > total Assets
6657365000
Quarters > 0 > balance Sheet > payables
114995000
Quarters > 0 > balance Sheet > short Term Debt
279560000
Quarters > 0 > balance Sheet > long Term Debt
1729366000
Quarters > 0 > balance Sheet > total Liabilities
3629615000
Quarters > 0 > balance Sheet > equity
3027750000
Quarters > 0 > cash Flow > net Income
-2186000
Quarters > 0 > cash Flow > depreciation
19606000
Quarters > 0 > cash Flow > change In Working Capital
365032000
Quarters > 0 > cash Flow > cash From Operations
60014000
Quarters > 0 > cash Flow > capital Expenditures
26635000
Quarters > 0 > cash Flow > cash From Investing
590259000
Quarters > 0 > cash Flow > cash From Financing
159163000
Quarters > 0 > cash Flow > net Change In Cash
808680000
Quarters > 0 > ratios > PE
-0.027876963884921446
Quarters > 0 > ratios > PB
14.290864384443891
Quarters > 0 > ratios > ROE
-0.072198827512179
Quarters > 0 > ratios > ROA
-0.032835814169720305
Quarters > 0 > ratios > FCF
33379000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.046970270502264856
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
668538000
Quarters > 1 > income Statement > cost Of Revenue
264795000
Quarters > 1 > income Statement > gross Profit
403743000
Quarters > 1 > income Statement > operating Expenses
402679000
Quarters > 1 > income Statement > operating Income
1064000
Quarters > 1 > income Statement > interest Expense
28686000
Quarters > 1 > income Statement > pretax Income
-38883000
Quarters > 1 > income Statement > net Income
36117000
Quarters > 1 > income Statement > eps
0.44011844702785696
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
82062000
Quarters > 1 > income Statement > income Tax Expense
-75000000
Quarters > 1 > income Statement > EBITDA
6960000
Quarters > 1 > income Statement > operating Margin
0.15915325680813955
Quarters > 1 > income Statement > total Other Income Expense Net
-39947000
Quarters > 1 > balance Sheet > cash
615496000
Quarters > 1 > balance Sheet > short Term Investments
1615304000
Quarters > 1 > balance Sheet > receivables
1091332000
Quarters > 1 > balance Sheet > inventories
308492000
Quarters > 1 > balance Sheet > total Current Assets
3828362000
Quarters > 1 > balance Sheet > property Plant Equipment
271240000
Quarters > 1 > balance Sheet > total Assets
6215256000
Quarters > 1 > balance Sheet > payables
118110000
Quarters > 1 > balance Sheet > short Term Debt
279247000
Quarters > 1 > balance Sheet > long Term Debt
1728575000
Quarters > 1 > balance Sheet > total Liabilities
3482856000
Quarters > 1 > balance Sheet > equity
2732400000
Quarters > 1 > cash Flow > net Income
36117000
Quarters > 1 > cash Flow > depreciation
17157000
Quarters > 1 > cash Flow > change In Working Capital
-307309000
Quarters > 1 > cash Flow > cash From Operations
-91704000
Quarters > 1 > cash Flow > capital Expenditures
22953000
Quarters > 1 > cash Flow > cash From Investing
-386532000
Quarters > 1 > cash Flow > cash From Financing
-4365000
Quarters > 1 > cash Flow > net Change In Cash
-477296000
Quarters > 1 > ratios > PE
0.44011844702785696
Quarters > 1 > ratios > PB
16.57187490118577
Quarters > 1 > ratios > ROE
1.3218050065876152
Quarters > 1 > ratios > ROA
0.5811023713262977
Quarters > 1 > ratios > FCF
-114657000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.17150408802491407
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
603633000
Quarters > 2 > income Statement > cost Of Revenue
237894000
Quarters > 2 > income Statement > gross Profit
365739000
Quarters > 2 > income Statement > operating Expenses
373632000
Quarters > 2 > income Statement > operating Income
-7893000
Quarters > 2 > income Statement > interest Expense
7821000
Quarters > 2 > income Statement > pretax Income
108391000
Quarters > 2 > income Statement > net Income
87980000
Quarters > 2 > income Statement > eps
1.0797211722546758
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
81484000
Quarters > 2 > income Statement > income Tax Expense
20411000
Quarters > 2 > income Statement > EBITDA
135665000
Quarters > 2 > income Statement > operating Margin
-1.3075825874330926
Quarters > 2 > income Statement > total Other Income Expense Net
116284000
Quarters > 2 > balance Sheet > cash
1092938000
Quarters > 2 > balance Sheet > short Term Investments
1274100000
Quarters > 2 > balance Sheet > receivables
974078000
Quarters > 2 > balance Sheet > inventories
279669000
Quarters > 2 > balance Sheet > total Current Assets
3776589000
Quarters > 2 > balance Sheet > property Plant Equipment
259869000
Quarters > 2 > balance Sheet > total Assets
6083159000
Quarters > 2 > balance Sheet > payables
97670000
Quarters > 2 > balance Sheet > short Term Debt
278915000
Quarters > 2 > balance Sheet > long Term Debt
1727797000
Quarters > 2 > balance Sheet > total Liabilities
3527306000
Quarters > 2 > balance Sheet > equity
2555853000
Quarters > 2 > cash Flow > net Income
87980000
Quarters > 2 > cash Flow > depreciation
19453000
Quarters > 2 > cash Flow > change In Working Capital
-71170000
Quarters > 2 > cash Flow > cash From Operations
25794000
Quarters > 2 > cash Flow > capital Expenditures
24862000
Quarters > 2 > cash Flow > cash From Investing
-702217000
Quarters > 2 > cash Flow > cash From Financing
1313226000
Quarters > 2 > cash Flow > net Change In Cash
637995000
Quarters > 2 > ratios > PE
1.0797211722546758
Quarters > 2 > ratios > PB
17.591800608250942
Quarters > 2 > ratios > ROE
3.4422949989690332
Quarters > 2 > ratios > ROA
1.4462880223909977
Quarters > 2 > ratios > FCF
932000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.001543984507142585
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
575145000
Quarters > 3 > income Statement > cost Of Revenue
229296000
Quarters > 3 > income Statement > gross Profit
345849000
Quarters > 3 > income Statement > operating Expenses
361504000
Quarters > 3 > income Statement > operating Income
-15655000
Quarters > 3 > income Statement > interest Expense
1825000
Quarters > 3 > income Statement > pretax Income
84565000
Quarters > 3 > income Statement > net Income
135184000
Quarters > 3 > income Statement > eps
1.6670653956665968
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
81091000
Quarters > 3 > income Statement > income Tax Expense
-50619000
Quarters > 3 > income Statement > EBITDA
104070000
Quarters > 3 > income Statement > operating Margin
-2.7219222978553232
Quarters > 3 > income Statement > total Other Income Expense Net
100220000
Quarters > 3 > balance Sheet > cash
454844000
Quarters > 3 > balance Sheet > short Term Investments
531505000
Quarters > 3 > balance Sheet > receivables
915501000
Quarters > 3 > balance Sheet > inventories
265316000
Quarters > 3 > balance Sheet > total Current Assets
2297481000
Quarters > 3 > balance Sheet > property Plant Equipment
247324000
Quarters > 3 > balance Sheet > total Assets
4474588000
Quarters > 3 > balance Sheet > payables
71955000
Quarters > 3 > balance Sheet > short Term Debt
680289000
Quarters > 3 > balance Sheet > long Term Debt
680289000
Quarters > 3 > balance Sheet > total Liabilities
2146923000
Quarters > 3 > balance Sheet > equity
2327665000
Quarters > 3 > cash Flow > net Income
135184000
Quarters > 3 > cash Flow > depreciation
17680000
Quarters > 3 > cash Flow > change In Working Capital
101265000
Quarters > 3 > cash Flow > cash From Operations
250166000
Quarters > 3 > cash Flow > capital Expenditures
24801000
Quarters > 3 > cash Flow > cash From Investing
-441739000
Quarters > 3 > cash Flow > cash From Financing
-32829000
Quarters > 3 > cash Flow > net Change In Cash
-230686000
Quarters > 3 > ratios > PE
1.6670653956665968
Quarters > 3 > ratios > PB
19.223214203933985
Quarters > 3 > ratios > ROE
5.807708583494618
Quarters > 3 > ratios > ROA
3.021149656683476
Quarters > 3 > ratios > FCF
225365000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.3918403185283711
Quarters > 3 > health Score
65
Valuation > metrics > PE
169.2603
Valuation > metrics > PB
14.290864384443891
Valuation > final Score
1
Valuation > verdict
476.7% Overvalued
Profitability > metrics > ROE
-0.072198827512179
Profitability > metrics > ROA
-0.05184104482708901
Profitability > metrics > Net Margin
-0.003076096087898109
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.1987829246139874
Risk > metrics > Interest Coverage
-0.07363724405091311
Risk > final Score
30
Risk > verdict
High
Liquidity > metrics > Current Ratio
10.687321159280708
Liquidity > metrics > Quick Ratio
9.882584177110923
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
14
Prev Profitabilities > 1
36
Prev Profitabilities > 2
59
Prev Risks > 0
30
Prev Risks > 1
26
Prev Risks > 2
14
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:26:18.539Z
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include axon officer safety plan; taser 10, taser7, taser X26P, taser X2, taser 7 CQ, and civilian series; cameras, such as axon body, axon flex, axon fleet, axon air, axon signal sidearm, axon signal vehicle, axon interview, and axon interview portable kit; software, including axon records, evidence, standards, commander, performance, auto-transcribe, justice, investigate, respond, and justice, my90, and redaction assistant; mobile applications, and training services, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. The company sells its products through its direct sales, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand bility to aggregate live video, data, and sensor feeds. It serves law enforcement, federal, correction, fire, EMS, campus, justice healthcare, retail, private security, and personal safety industries. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$822.5
Analyst Picks
Strong Buy
7
Buy
7
Hold
3
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 51.42% of the total shares of Axon Enterprise Inc.
1.
Vanguard Group Inc(11.3844%)
since
2025/06/30
2.
BlackRock Inc(9.6467%)
since
2025/06/30
3.
State Street Corp(4.0454%)
since
2025/06/30
4.
FMR Inc(3.7636%)
since
2025/06/30
5.
Geode Capital Management, LLC(2.6396%)
since
2025/06/30
6.
Capital World Investors(2.3432%)
since
2025/06/30
7.
Franklin Resources Inc(2.1536%)
since
2025/06/30
8.
Amvescap Plc.(2.1099%)
since
2025/06/30
9.
Sands Capital Management, LLC(2.0525%)
since
2025/06/30
10.
AllianceBernstein L.P.(1.3602%)
since
2025/06/30
11.
JPMorgan Chase & Co(1.1555%)
since
2025/06/30
12.
Morgan Stanley - Brokerage Accounts(1.1463%)
since
2025/06/30
13.
Vestor Capital Partners(1.0618%)
since
2025/06/30
14.
Westfield Capital Management Company, L.P.(1.0064%)
since
2025/06/30
15.
NORGES BANK(0.9813%)
since
2025/06/30
16.
Bank of New York Mellon Corp(0.9683%)
since
2025/06/30
17.
Northern Trust Corp(0.9327%)
since
2025/06/30
18.
UBS Asset Mgmt Americas Inc(0.9121%)
since
2025/06/30
19.
BROADWOOD CAPITAL Inc(0.8844%)
since
2025/06/30
20.
Massachusetts Financial Services Company(0.8674%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.